Man J - Search Results

1

Man J, Ritchie G, Links M, Lord S, Lee CK. Man J, et al. Asia Pac J Clin Oncol. 2019 Jun;15(3):191. doi: 10.1111/ajco.13132. Epub 2019 Feb 27. Asia Pac J Clin Oncol. 2019. PMID: 30815961 No abstract available.

2

Treatment-related toxicities of immune checkpoint inhibitors in advanced cancers: A meta-analysis.

Man J, Ritchie G, Links M, Lord S, Lee CK. Man J, et al. Asia Pac J Clin Oncol. 2018 Jun;14(3):141-152. doi: 10.1111/ajco.12838. Epub 2018 Jan 19. Asia Pac J Clin Oncol. 2018. PMID: 29349927

3

Checkpoint Inhibitors in Metastatic EGFR-Mutated Non-Small Cell Lung Cancer-A Meta-Analysis.

Lee CK, Man J, Lord S, Links M, Gebski V, Mok T, Yang JC. Lee CK, et al. Among authors: man j. J Thorac Oncol. 2017 Feb;12(2):403-407. doi: 10.1016/j.jtho.2016.10.007. Epub 2016 Oct 17. J Thorac Oncol. 2017. PMID: 27765535 Free article.

4

Clinical and Molecular Characteristics Associated With Survival Among Patients Treated With Checkpoint Inhibitors for Advanced Non-Small Cell Lung Carcinoma: A Systematic Review and Meta-analysis.

Lee CK, Man J, Lord S, Cooper W, Links M, Gebski V, Herbst RS, Gralla RJ, Mok T, Yang JC. Lee CK, et al. Among authors: man j. JAMA Oncol. 2018 Feb 1;4(2):210-216. doi: 10.1001/jamaoncol.2017.4427. JAMA Oncol. 2018. PMID: 29270615 Free PMC article.

5

Defining the Most Appropriate Primary End Point in Phase 2 Trials of Immune Checkpoint Inhibitors for Advanced Solid Cancers: A Systematic Review and Meta-analysis.

Ritchie G, Gasper H, Man J, Lord S, Marschner I, Friedlander M, Lee CK. Ritchie G, et al. Among authors: man j. JAMA Oncol. 2018 Apr 1;4(4):522-528. doi: 10.1001/jamaoncol.2017.5236. JAMA Oncol. 2018. PMID: 29470579 Free PMC article.

6

Pathways to diagnosis of non-small cell lung cancer: a descriptive cohort study.

Purdie S, Creighton N, White KM, Baker D, Ewald D, Lee CK, Lyon A, Man J, Michail D, Miller AA, Tan L, Currow D, Young JM. Purdie S, et al. Among authors: man j. NPJ Prim Care Respir Med. 2019 Feb 8;29(1):2. doi: 10.1038/s41533-018-0113-7. NPJ Prim Care Respir Med. 2019. PMID: 30737397 Free PMC article.

7

Clinical Equipoise for Trials of Novel Biologic Therapies, Therapeutic Success Rates, and Predictors of Success: A Meta-Analysis.

Cho D, Roncolato FT, Man J, Simes J, Lord SJ, Links MJ, Lee CK. Cho D, et al. Among authors: man j. JCO Precis Oncol. 2017 Nov;1:1-12. doi: 10.1200/PO.17.00062. JCO Precis Oncol. 2017. PMID: 35172509

8

Response Rate and Survival at Key Timepoints With PD-1 Blockade vs Chemotherapy in PD-L1 Subgroups: Meta-Analysis of Metastatic NSCLC Trials.

Man J, Millican J, Mulvey A, Gebski V, Hui R. Man J, et al. JNCI Cancer Spectr. 2021 Jan 27;5(3):pkab012. doi: 10.1093/jncics/pkab012. eCollection 2021 Jun. JNCI Cancer Spectr. 2021. PMID: 34084999 Free PMC article.

9

Novel Drug Delivery Systems: An Important Direction for Drug Innovation Research and Development.

Chen Q, Yang Z, Liu H, Man J, Oladejo AO, Ibrahim S, Wang S, Hao B. Chen Q, et al. Among authors: man j. Pharmaceutics. 2024 May 16;16(5):674. doi: 10.3390/pharmaceutics16050674. Pharmaceutics. 2024. PMID: 38794336 Free PMC article. Review.

10

Proteomic dissection of vanishing white matter pathogenesis.

Man JHK, Zarekiani P, Mosen P, de Kok M, Debets DO, Breur M, Altelaar M, van der Knaap MS, Bugiani M. Man JHK, et al. Cell Mol Life Sci. 2024 May 24;81(1):234. doi: 10.1007/s00018-024-05258-4. Cell Mol Life Sci. 2024. PMID: 38789799 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

668 results

Search Page